Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for prostate cancer, hereditary, 5.
4 publications have been identified in PubMed for prostate cancer, hereditary, 5. Research spans Case Report / Case Series (25%), Basic Science / Preclinical (25%), and Epidemiology / Natural History (25%).
Dupont WD (2025). [PMID: 39874495](https://pubmed.ncbi.nlm.nih.gov/39874495/). *JCO precision oncology*. [Gene Therapy / Novel Therapeutics]
Aoki M (2025). [PMID: 40295048](https://pubmed.ncbi.nlm.nih.gov/40295048/). *Anticancer research*. [Basic Science / Preclinical]
Zhang Y (2024). [PMID: 38736618](https://pubmed.ncbi.nlm.nih.gov/38736618/). *American journal of clinical and experimental urology*. [Case Report / Case Series]
Pilenzi L (2024). [PMID: 39001389](https://pubmed.ncbi.nlm.nih.gov/39001389/). *Cancers*. [Epidemiology / Natural History]
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 2:17 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center